Uso de medicamentos de precisión para detectar daños cognitivos en Madrid

The study, initiated in 2023, will continue with a second phase following the success of the participation obtained at the start of the research. The results obtained so far provide a solid foundation for advancing the project’s objectives and making a significant difference between early detection and attention to cognitive decline. Early alertness to health changes can not only facilitate an early diagnosis of cognitive deficiency and the development of a more effective and careful personalized treatment but also enable individuals to actively engage in self-care and make decisions about their future.

In this study, ten healthcare professionals and physicians were involved in this center, which is integrated into the Medical Assistance Center, and have already recruited over 140 patients aged between 55 and 70, without a diagnosis of cognitive deficiency. They all underwent different questionnaires, complemented by tests such as voice recording, blood sample extraction and processing, and gait speed measurement.

Predicting Neurodegeneration

For the scientific team, the project is a unique opportunity to advance in understanding the early signs of cognitive deficiency in the population. The dendrite study is funded by the Carlos III Health Institute. Along with the Madrid community, seven other regions are participating.

The activity is coordinated in the Madrid community by Milagros Rico Blázquez, a specialist in family and community medical care from the primary care unit, and Pedro Otones Reyes, an assistant who leads the clinical care group at the San Andrés Health Center.

Nationally, the Dendritite Project is led by experts from the Biomedical Research Institute in Salamanca and scientists from the Carlos III Health Institute and the Biomedical Research Center in the field of frailty and healthy aging.

According to the primary care team from the Madrid Health Service, «the project is a unique opportunity to advance in the understanding of the early signs of cognitive deficiency in the population. Through simple tests, such as collecting blood samples, validating voice analysis, completing questionnaires related to their lifestyle and patients, neurodegeneration.»

Estimates from the National Statistics Institute indicate that over 700,000 people over 40 years old could present dementia in our country by 2050.